Trial Profile
A multicentre study of Infliximab versus Adalimumab in patients with severe uveitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- 08 Feb 2016 New trial record